Last reviewed · How we verify
NCT04336280
Detrusor Underactivity: Presentation and Urodynamic Characteristics
trial testing Symptom questionnaire in Detrusor Underactivity in 206 participants. Completed in 25 March 2020.
28 February 2020
Quick facts
| Lead sponsor | Mutah University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 206 |
| Start date | 20 January 2020 |
| Primary completion | 28 February 2020 |
| Estimated completion | 25 March 2020 |
| Sites | 1 location across Jordan |
Drugs / interventions tested
- Symptom questionnaire
- Urodynamics
Conditions studied
- Detrusor Underactivity — all drugs for Detrusor Underactivity →
Sponsor
Mutah University
Who can join
Adults 18 to 87, any sex, with Detrusor Underactivity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Detrusor underactivity (DU) is a known disease of the muscles of the urinary bladder that defined as a weak contraction of the muscle resulting in a failure to achieve complete bladder emptying. Recently, DU as a cause of Lower Urinary Tract Symptoms in both men and women has been increasingly gaining attention. There is a major issue in differentiation of underactive bladder symptoms and other causes of lower urinary tract symptoms such as detrusor hyperactivity and impaired contractility (DHIC), hypersensitive bladder (HSB), detrusor overactivity (DO), bladder outlet obstruction (BOO) and Dysfunctional Voiding (DV). Urodynamics (UDS) is the standard diagnostic tool, it includes invasive recording of the pressure that is produced when the bladder muscle contracts via pressure sensors introduced in the urinary bladder through special types of urethral catheters. This study aims to determine the prevalence of DU along with its symptomatic and urodynamics (UDS) characteristics of DU in Jordanian population through a retrospective chart review.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Prevalence of Detrusor Underactivity and its Symptoms Co-relation with Urodynamic Study Findings in Patients with Lower Urinary Tract Symptoms.
Sawaqed F, Abughosh Z, Suoub M. · · 2020 · cited 6× · PMID 33062620 · DOI 10.2147/rru.s264237
Verify or expand the search:
- PubMed search for NCT04336280
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Symptom questionnaire
Trials testing the same drug.
- NCT02802722 — Does Vitamin D Supplementation Enhance Resolution of Inflammation After Community-acquired Pneumonia? · NA · completed
Other Mutah University trials
Trials by the same sponsor.
- NCT06765382 — Association of Vitamin D Intake, and Associated Factors with Low Back Pain: a Retrospective Cohort Study · completed
- NCT06103058 — The Prevalence of Fibromyalgia in Adults at Al-Karak Jordan a Cross-sectional Study · unknown
- NCT05581264 — Diabetes Self-Management Educational Program · NA · completed
- NCT05229796 — Pharmacokinetics and Bioequivalence of Two Empagliflozin, With Evaluation in Healthy Jordanian Subjects Under Fasting an · NA · completed
- NCT04309890 — Arabic Translation and Validation of the (Overactive Bladder Symptom Score) OABSS · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04336280 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mutah University
- Last refreshed: 7 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04336280.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing